CW February 2010
Volume 19Issue Number 2 February 2010 ISSN 1059380 Chronic GVHD Associated with Lower Risk of Relapse in Reduced-Intensity Transplants for Myeloma PatientsChronic graft-versus-host disease (GVHD) is associated with a lower risk of relapse and superior progression-free survival (PFS) for myeloma patients who receive a reduced-intensity allogenic hematopoietic stem cell transplant (HSCT).
Sources and Additional Reading: Sandra Cohen of the University of Montreal, Montreal, Quebec, Canada, at the American Society of Hematology annual meeting in New Orleans. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW February 2010Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
